Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Stopped study was never opened to accrual
Conditions
- Ovarian Papillary Serous Carcinoma
- Ovarian Serous Cystadenocarcinoma
- Recurrent Fallopian Tube Cancer
- Recurrent Ovarian Epithelial Cancer
- Recurrent Ovarian Germ Cell Tumor
- Recurrent Primary Peritoneal Cavity Cancer
Interventions
- DRUG: metformin hydrochloride
- DRUG: carboplatin
- DRUG: paclitaxel
- OTHER: laboratory biomarker analysis
Sponsor
Fox Chase Cancer Center
Collaborators